DCF Advisers’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,000
Closed -$217K 108
2024
Q2
$217K Buy
+2,000
New +$236K 0.11% 85

Other funds holding ZBH

DCF Advisers's ZBH Position: Q2 2026 in Review

DCF Advisers held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 30,500 shares worth $2.63M. The position accounts for 0.46% of the portfolio, ranked #39.

DCF Advisers first reported a position in ZBH in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.03M in Q1 2025. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • DCF Advisers held 30,500 shares of Zimmer Biomet worth $2.63M as of Q2 2026.
  • DCF Advisers left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up 0.46% of DCF Advisers's portfolio in Q2 2026, its #39 holding.
  • DCF Advisers first reported a position in Zimmer Biomet in Q2 2023 and has held it in 13 quarters since.
  • DCF Advisers's Zimmer Biomet position peaked at $3.03M in Q1 2025.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.